Works matching IS 00912700 AND DT 2017 AND VI 57 AND IP 11

Results: 15

BACE1 Inhibitor Lanabecestat (AZD3293) in a Phase 1 Study of Healthy Japanese Subjects: Pharmacokinetics and Effects on Plasma and Cerebrospinal Fluid Aβ Peptides.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1460, doi. 10.1002/jcph.950

By:

Sakamoto, Kei;
Matsuki, Shunji;
Matsuguma, Kyoko;
Yoshihara, Tatsuya;
Uchida, Naoki;
Azuma, Fumihiko;
Russell, Muir;
Hughes, Glen;
Haeberlein, Samantha Budd;
Alexander, Robert C.;
Eketjäll, Susanna;
Kugler, Alan R.

Publication type:

Article

Utilization of the Bridging Strategy for the Development of New Drugs in Oncology to Avoid Drug Lag.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1479, doi. 10.1002/jcph.951

By:

Kogure, Seiji;
Koyama, Nobuyuki;
Hidaka, Shinji

Publication type:

Article

The Effect of Renal Impairment on the Pharmacokinetics and Pharmacodynamics of Ertugliflozin in Subjects With Type 2 Diabetes Mellitus.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1432, doi. 10.1002/jcph.955

By:

Sahasrabudhe, V.;
Terra, S. G.;
Hickman, A.;
Saur, D.;
Shi, H.;
O'Gorman, M.;
Zhou, Z.;
Cutler, D. L.

Publication type:

Article

Notable Drug-Drug Interaction Between Etizolam and Itraconazole in Poor Metabolizers of Cytochrome P450 2C19.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1491, doi. 10.1002/jcph.956

By:

Yamamoto, Takehito;
Furihata, Kenichi;
Hisaka, Akihiro;
Moritoyo, Takashi;
Ogoe, Kazuaki;
Kusayama, Shizuko;
Motohashi, Keiju;
Mori, Akiko;
Iwatsubo, Takeshi;
Suzuki, Hiroshi

Publication type:

Article

Issue Information.

Published in:: Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1363, doi. 10.1002/jcph.1033
Publication type:: Article

Addressing Antiretroviral Therapy-Associated Drug-Drug Interactions in Patients Requiring Treatment for Opportunistic Infections in Low-Income and Resource-Limited Settings.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1387, doi. 10.1002/jcph.978

By:

Chastain, Daniel B.;
Franco‐Paredes, Carlos;
Stover, Kayla R.

Publication type:

Article

Optimization of Maternal Magnesium Sulfate Administration for Fetal Neuroprotection: Application of a Prospectively Constructed Pharmacokinetic Model to the BEAM Cohort.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1419, doi. 10.1002/jcph.941

By:

Brookfield, Kathleen F.;
Elkomy, Mohammed;
Su, Felice;
Drover, David R.;
Carvalho, Brendan

Publication type:

Article

Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1400, doi. 10.1002/jcph.942

By:

Cheung, Eric M.;
Edenfield, William J.;
Mattar, Bassam;
Anthony, Stephen P.;
Mutch, Peter J.;
Chanas, Brian;
Smith, Mark;
Hepner, Adrian

Publication type:

Article

Lucerastat, an Iminosugar for Substrate Reduction Therapy: Pharmacokinetics, Tolerability, and Safety in Subjects With Mild, Moderate, and Severe Renal Function Impairment.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1425, doi. 10.1002/jcph.944

By:

Guérard, Nicolas;
Zwingelstein, Christian;
Dingemanse, Jasper

Publication type:

Article

Approach to Fingolimod-Induced Lymphopenia in Multiple Sclerosis Patients: Do We Have a Roadmap?

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1415, doi. 10.1002/jcph.945

By:

Avasarala, Jagannadha;
Jain, Sandip;
Urrea‐Mendoza, Enrique

Publication type:

Article

Pharmacokinetic Characterization and Dose Selection of a Novel Sumatriptan Nasal Spray Formulation, DFN-02.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1472, doi. 10.1002/jcph.946

By:

Pal, Arindam;
Gautam, Anirudh;
Munjal, Sagar

Publication type:

Article

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Novel CRTH2 Antagonist BI 1021958 at Single Oral Doses in Healthy Men and Multiple Oral Doses in Men and Women With Well-Controlled Asthma.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1444, doi. 10.1002/jcph.947

By:

Fowler, Andy;
Koenen, Rüdiger;
Hilbert, James;
Blatchford, Jon;
Kappeler, Dominik;
Benediktus, Ewald;
Wood, Chester;
Gupta, Abhya

Publication type:

Article

Effect of Hepatic Impairment on Eluxadoline Pharmacokinetics.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1454, doi. 10.1002/jcph.964

By:

Marbury, Thomas C.;
Berg, Jolene Kay;
Dove, Leonard S.;
Covington, Paul S.

Publication type:

Article

A Review of Moxifloxacin for the Treatment of Drug-Susceptible Tuberculosis.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1369, doi. 10.1002/jcph.968

By:

Naidoo, Anushka;
Naidoo, Kogieleum;
McIlleron, Helen;
Essack, Sabiha;
Padayatchi, Nesri

Publication type:

Article

An Open-Label Dose-Finding Study of Allopurinol to Target Defined Reduction in Urate Levels in Hemodialysis Patients.

Published in:

Journal of Clinical Pharmacology, 2017, v. 57, n. 11, p. 1409, doi. 10.1002/jcph.939

By:

Rutherford, Elaine;
Stewart, Graham;
Houston, J. Graeme;
Jardine, Alan G.;
Mark, Patrick B.;
Struthers, Allan D.

Publication type:

Article